Brussels - Delayed Quote EUR
UCB SA (UCB.BR)
147.35
+0.60
+(0.41%)
At close: 5:35:29 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
1,242,000
1,242,000
761,000
1,119,000
1,553,000
Investing Cash Flow
282,000
282,000
-440,000
-1,580,000
-487,000
Financing Cash Flow
-818,000
-818,000
-308,000
70,000
-1,119,000
End Cash Position
1,573,000
1,573,000
861,000
859,000
1,244,000
Capital Expenditure
-322,000
-322,000
-316,000
-371,000
-493,000
Issuance of Debt
572,000
572,000
597,000
1,025,000
--
Repayment of Debt
-756,000
-756,000
-424,000
-546,000
-716,000
Repurchase of Capital Stock
-162,000
-162,000
-40,000
-42,000
-60,000
Free Cash Flow
920,000
920,000
445,000
748,000
1,060,000
12/31/2021 - 1/4/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TUB.BR Financière de Tubize SA
116.40
+0.52%
ARGX.BR argenx SE
531.60
+0.76%
ARGX argenx SE
600.51
+0.99%
MLTX MoonLake Immunotherapeutics
39.45
-0.15%
MRUS Merus N.V.
44.36
+6.05%
VERA Vera Therapeutics, Inc.
23.47
+5.06%
IMVT Immunovant, Inc.
15.07
+4.29%
IMTX Immatics N.V.
4.6700
+3.55%
KYMR Kymera Therapeutics, Inc.
33.56
+9.32%
GLPG Galapagos NV
26.49
+3.88%